Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 14 of 14

Full-Text Articles in Entire DC Network

Technology Evaluation: Pro-542, Progenics Pharmaceuticals Inc., Muhammad Mukhtar, Zahida Parveen, Roger J Pomerantz Dec 2000

Technology Evaluation: Pro-542, Progenics Pharmaceuticals Inc., Muhammad Mukhtar, Zahida Parveen, Roger J Pomerantz

Department of Medicine Faculty Papers

Progenics's rCD4-IgG2 (PRO-542) is a recombinant fusion protein, which has been developed using the company's Universal Antiviral Binding (UnAB) technology, and is in phase I/II clinical trials for the treatment of human immunodeficiency virus type I (HIV-1) infection [273391]. At the beginning of 1997, Progenics received a Phase II Small Business Innovation Research Program (SBIR) grant from the National Institute of Allergy and Infectious diseases (NIAID) to fund the development of PRO-542 [236048]. A further grant of $2.7 million was awarded in August 1998 for the clinical evaluation of PRO-542 and other anti-HIV therapies [294200]. Progenics is collaborating with the …


Food For Thought On Cognitive Scripts And Genetically Engineered Food, Ibpp Editor Mar 2000

Food For Thought On Cognitive Scripts And Genetically Engineered Food, Ibpp Editor

International Bulletin of Political Psychology

This article identifies some of the common thought sequences seemingly harbored by members of the sociopolitical opposition to the production and sale of genetically engineered food.


The Risks And Benefits Of Genetically Modified Crops: A Multidisciplinary Perspective, Garry D. Peterson, Saul Cunningham, Lisa Deutsch, Jon Erickson, Allyson Quinlan, Ernesto Ráez-Luna, Robert Tinch, Max Troell, Peter Woodbury, Scot Zens Mar 2000

The Risks And Benefits Of Genetically Modified Crops: A Multidisciplinary Perspective, Garry D. Peterson, Saul Cunningham, Lisa Deutsch, Jon Erickson, Allyson Quinlan, Ernesto Ráez-Luna, Robert Tinch, Max Troell, Peter Woodbury, Scot Zens

Dartmouth Scholarship

Worldwide, the area planted in genetically modified (GM) crops has increased dramatically in recent years. Between 1996 and 1999, it rose from 1.6 X 106 ha to more than 35 X 106 ha (James 1998, May 1999). This rapid increase has provoked an explosion of concern, particularly in Europe, over the health and environmental impacts of these crops. Despite claims of safety and warnings against popular panic, public concern over GM crops has resulted in changes in their marketing, labeling, planting, and trade. These changes have fueled an increasingly heated debate among environmental advocates, critics of industrial agriculture, …


Reflections On Science And Technology, Ursula Goodenough Mar 2000

Reflections On Science And Technology, Ursula Goodenough

Biology Faculty Publications & Presentations

Science and technology are frequently confused. This essay points out the bases for this confusion and then focuses on a basic distinction, namely, that whereas science brings us information that we have little choice but to absorb and reflect upon, technology is something that humans elect to do and, hence, can also elect not to do. It is proposed that technological ethics are most cogently undertaken with scientific understanding as the linchpin and religious/artistic sensibilities as the muse.


Cs 635 Medical Ethics, James R. Thobaben Jan 2000

Cs 635 Medical Ethics, James R. Thobaben

Syllabi

Beauchamp & Walters, Contemporary Issues in Bioethics (5th edition). Thobaben, JR Bioethics as Christian Ethics (draft of upcoming book; provided) Thobaben, JR "The Impact of Managed Care on the Moral Character of Rehabilitation Institutions" Journal of Head Trauma Rehabilitation 1997; 12(1):10-20. (on library reserve) Thobaben, JR "A United Methodist Approach to End-of-Life Decisions: Intentional Ambiguity or Ambiguous Intentions" Christian Bioethics 1997; 3 (3): 222-248. (on library reserve) "Durham Declaration"(on library reserve or on Web)


Stranger In A Strange Land: Biotechnology And The Federal Circuit, Lawrence M. Sung Jan 2000

Stranger In A Strange Land: Biotechnology And The Federal Circuit, Lawrence M. Sung

Faculty Scholarship

No abstract provided.


Normalizing Novelty: Regulating Biotechnological Risk At The U.S. Epa, Les Levidow, Susan Carr Jan 2000

Normalizing Novelty: Regulating Biotechnological Risk At The U.S. Epa, Les Levidow, Susan Carr

RISK: Health, Safety & Environment (1990-2002)

Drs. Levidow and Carr examine EPA's regulation of biotechnology in the field of genetically modified organisms.


The Intellectual And Technical Property Components Of Pro-Vitamin A Rice (Goldenricetm): A Preliminary Freedom-To-Operate Review, R. David Kryder, Stanley P. Kowalski, Anatole F. Krattiger Jan 2000

The Intellectual And Technical Property Components Of Pro-Vitamin A Rice (Goldenricetm): A Preliminary Freedom-To-Operate Review, R. David Kryder, Stanley P. Kowalski, Anatole F. Krattiger

Law Faculty Scholarship

Rice is a staple food for millions of people, predominantly in Asia, but lacks essential nutritional components such as Vitamin A. This is very important for over 180 million children and women of child bearing age who suffer from Vitamin A deficiency in Asia alone. For this reason, an improvement was made under an effort led by Profs. Ingo Potrykus and Peter Beyer by inserting several genes into rice to produce an improved product called GoldenRice. Because GoldenRice has the potential to be easily integrated into the farming systems of the world's poorer regions, the advent of GoldenRice promises to …


Biotechnology, Food, And Agriculture Disputes Or Food Safety And International Trade, Shirley A. Coffield Jan 2000

Biotechnology, Food, And Agriculture Disputes Or Food Safety And International Trade, Shirley A. Coffield

Canada-United States Law Journal

biotechnology, agriculture, and food safety--Canada, biotechnology, agriculture, and food safety--United States


Discussion Following The Remarks Of Ms. Coffield And Mr. Frechette, Discussion Jan 2000

Discussion Following The Remarks Of Ms. Coffield And Mr. Frechette, Discussion

Canada-United States Law Journal

biotechnology, agriculture, and food safety--Canada, biotechnology, agriculture, and food safety--United States


Introduction: Biotechnology, Food, And Agriculture Disputes Or Food Safety And International Trade, Henry T. King Jr. Jan 2000

Introduction: Biotechnology, Food, And Agriculture Disputes Or Food Safety And International Trade, Henry T. King Jr.

Canada-United States Law Journal

biotechnology, agriculture, and food safety--Canada, biotechnology, agriculture, and food safety--United States


Biotechnology, Food, And Agriculture Disputes Or Food Safety And International Trade, Serge Frechette Jan 2000

Biotechnology, Food, And Agriculture Disputes Or Food Safety And International Trade, Serge Frechette

Canada-United States Law Journal

biotechnology, agriculture, and food safety--Canada, biotechnology, agriculture, and food safety--United States


Biotechnology And The Legal Constitution Of The Self: Managing Identity In Science, The Market, And Society, Jonathan Kahn Jan 2000

Biotechnology And The Legal Constitution Of The Self: Managing Identity In Science, The Market, And Society, Jonathan Kahn

Faculty Scholarship

This article considers how certain ideas underlying the tort of appropriation may enable use more effectively to deal with the problems presented by a case such Moore v. Regents of the University of California which dealt with property rights of Moore’s spleen cells. First, the author explores how the tort of appropriation of identity opens up new approaches to inform and perhaps supplement principles of property law as a guide to managing genetic information or other materials that seem intimately bound up with a particular human subject. Secondly, the author analyzes how the various opinions produced by the Supreme Court …


Symposium: Patent Rights And Licensing, Michael S. Baram, Ashley Stevens, Thomas Meyers, Michael J. Meurer Jan 2000

Symposium: Patent Rights And Licensing, Michael S. Baram, Ashley Stevens, Thomas Meyers, Michael J. Meurer

Faculty Scholarship

This panel will discuss intellectual property - the patent incentive, patentability issues, licensing, and litigation-related matters. It will be moderated by Dr. Ashley Stevens, the Director of the Office of Technology Transfer at Boston University. Ashley has multiple degrees, including a doctorate in physical chemistry from Oxford University. He has worked in the biotech industry for a number of years, mostly with startup companies and academic research organizations such as the Dana Farber Cancer Institute, where he was also Director of Technology Transfer. Ashley was instrumental in the startup and operations of firms such as Biotechnica International, and started his …